---  
layout: startup_page  
title: "Pathalys Pharma"  
id: "pathalys.com"  
permalink: "/pathalyspharmapathalys.com08202024/"  
website: "https://www.pathalys.com/"  
funding_round: "Series B"  
funding_amount: "$105M"  
investors: "TCGX, JP Morgan Life Sciences Private Capital, Samsara BioCapital, Marshall Wace, KB Investment, JPS Growth Investment Limited Partnership, Catalys Pacific, DaVita Venture Group"  
about: "Pathalys Pharma is a late-stage clinical biopharmaceutical company focused on developing treatments for end-stage kidney disease (ESKD). Their lead asset is upacicalcet, a novel calcimimetic, and they are actively pursuing other solutions for ESKD patients. The company was co-founded by Catalys Pacific and DaVita Venture Group."  
markets: "Biopharmaceutical, Healthtech, Biotechnology, Pharmaceuticals, Drug Discovery"  
hq: "Raleigh, North Carolina, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/pathalys"  
twitter: "https://twitter.com/PathalysPharma"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/pathalys?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/469565-11"  

date_display: "20-Aug-2024"  
date: "2024-08-20"

# SEO Optimization  
meta_title: "Pathalys Pharma - Series B Funding ($105M)"  
meta_description: "Pathalys Pharma, Pathalys Pharma is a late-stage clinical biopharmaceutical company focused on developing treatments for end-stage kidney disease (ESKD). Their lead as..."  
meta_keywords: "Pathalys Pharma, Biopharmaceutical, Healthtech, Biotechnology, Pharmaceuticals, Drug Discovery, Series B funding"  
canonical_url: "https://startup.projectstartups.com/pathalyspharmapathalys.com08202024/"  
---